Commonwealth legislation

Therapeutic Goods (Listing) Notice 2012 (No. 4)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

This notice temporarily allows dietary supplements and natural medicines containing calcified Lithothamnion tophiforme (a calcified red algae, also known as red seaweed) to be sold in Australia.

What it does:

Adds this specific algae to the Australian Register of Therapeutic Goods (ARTG) as a "listed" medicine (a lower-risk category for complementary medicines)
Only applies to products where this algae is an active (therapeutic) ingredient
Restriction: Products must be for oral use only (tablets, capsules, powders taken by mouth—not creams or injections)

Why it exists: This is a temporary "bridge" measure. Instead of waiting months or years for formal regulations to be amended, this notice immediately permits these products to be legally supplied. It automatically expires once the Therapeutic Goods Regulations 1990 are formally updated to include this ingredient.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods (Listing) Notice 2012 (No. 4).

Therapeutic Goods (Listing) Notice 2012 (No. 4)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2012 (No. 4)

I, JILL JEPSON, Acting National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:

preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘calcified Lithothamnion tophiforme’ as a therapeutically active ingredient, subject to the following condition:
- the preparations are for oral use only.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.

Dated this 14th day of December 2012

(Signed by)

Jill Jepson

Delegate of the Minister for Health

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Therapeutic Goods (Listing) Notice 2012 (No. 4)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2012 (No. 4)

preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘calcified Lithothamnion tophiforme’ as a therapeutically active ingredient, subject to the following condition:
- the preparations are for oral use only.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Dated this 14th day of December 2012

(Signed by)

Jill Jepson

Delegate of the Minister for Health